AbCellera Biologics GAAP EPS of -$0.49 beats by $0.15, revenue of $75.1M beats by $38.81M
Source: SeekingAlpha
2026-02-24 16:12:54 ET
More on AbCellera Biologics
- AbCellera Biologics Inc. (ABCL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- AbCellera: Losing Its Undeserved Premium
- AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
- OpenAI considers backing AI-led drug discovery firms: report
- AbCellera settles patent litigation with Bruker over microfluidic device tech
Read the full article on Seeking Alpha
For further details see:
AbCellera Biologics GAAP EPS of -$0.49 beats by $0.15, revenue of $75.1M beats by $38.81M
AbCellera Biologics Inc.
NASDAQ: ABCL
ABCL Trading
4.45% G/L:
$3.635 Last:
929,335 Volume:
$3.50 Open:
ABCL Latest News
ABCL Stock Data
$932,616,409
209,507,193
7.67%
46
N/A
Biotechnology & Life Sciences
Healthcare
CA
Vancouver
